Recently, it has been reported that SCD1 expression and activity are closely related to cancer pathogenesis and tumor malignancy, because tumor cells obtain most of fatty acid from de novo synthesis [26], and SCD1 inhibitors shows potential anticancer effect both in vivo and in vitro [13]. The gene discussed is SCD; the disease is cancer.